Wagner Wealth Management (South Carolina)’s Biogen BIIB Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-32	Closed	-$9K	–	284
2022 Q3	$9K	Hold	32	–	–	0.01%	432
2022 Q2	$7K	Buy	+32	New	+$6.54K	0.01%	488
2022 Q1	–	Sell	-37	Closed	-$9K	–	252
2021 Q4	$9K	Hold	37	–	–	0.01%	503
2021 Q3	$10K	Sell	37 -75	-67%	-$24.6K	0.01%	467
2021 Q2	$39K	Buy	112 +107	+2,140%	+$32.4K	0.03%	283
2021 Q1	$1K	Buy	+5	New	+$1.35K	﹤0.01%	618
2018 Q3	$9K	Hold	25	–	–	0.01%	426
2018 Q2	$7K	Buy	+25	New	+$7.03K	0.01%	431

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s BIIB Position: Q4 2022 in Review

Wagner Wealth Management (South Carolina) sold out of Biogen (BIIB) in Q4 2022, closing a stake of 32 shares — an estimated $9K sold.

Wagner Wealth Management (South Carolina) first reported a position in BIIB in Q2 2018 and held it in 8 quarters. The position peaked at $39K in Q2 2021. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

Wagner Wealth Management (South Carolina) reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
Wagner Wealth Management (South Carolina) sold 32 Biogen shares in Q4 2022, an estimated $9K.
Wagner Wealth Management (South Carolina) first reported a position in Biogen in Q2 2018 and held it in 8 quarters.
Wagner Wealth Management (South Carolina)'s Biogen position peaked at $39K in Q2 2021.
1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.